Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries-Reference-Cited by-同舟云学术

Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries

Author:

Simms Kate T.¹²,Smith Megan A.¹²³,Lew Jie-Bin¹²,Kitchener Henry C.⁴,Castle Philip E.⁵⁶,Canfell Karen¹²³

Affiliation:

1. Cancer Research Division; Cancer Council NSW; Woolloomooloo Sydney NSW Australia

2. Prince of Wales Clinical School; The University of New South Wales; Australia

3. School of Public Health; University of Sydney; Australia

4. Institute of Cancer Sciences, University of Manchester; United Kingdom

5. Department of Epidemiology and Population Health; Albert Einstein College of Medicine; Bronx NY

6. Global Coalition against Cervical Cancer; Arlington VA

Funder

National Health and Medical Research Council

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference50 articles.

4. Lew JB Simms K Smith MA 2014

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献